Crystax Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Crystax Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company specializing in the development of new therapeutic molecules for treating cancer. The company identifies and develops new lead compounds through a combination of structural and biophysical techniques for the process of drug discovery.

Contact Information

Website
www.crystax.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Barcelona Science Park
  • Josep Samitier 1-5
  • 08028 Barcelona
  • Spain
+34 934 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crystax Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 27-Jan-2009 00.000 Completed Product Development
3. Grant 16-Nov-2007 00000 00.000 Completed
2. Early Stage VC 20-Nov-2006 $3.83M $6.34M Completed Product Development
1. Early Stage VC 06-May-2004 $2.51M $2.51M Completed Product Development
To view Crystax Pharmaceuticals’s complete valuation and funding history, request access »

Crystax Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Christian Fernández Chief Executive Officer
To view Crystax Pharmaceuticals’s complete executive team members history, request access »

Crystax Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Barcelona Empren Venture Capital Minority 000 0000 000000 0
Invertec Venture Capital Minority 000 0000 000000 0
Najeti Capital Venture Capital Minority 000 0000 000000 0
To view Crystax Pharmaceuticals’s complete investors history, request access »